Ann: Final Director's Interest Notice, page-16

I could be wrong, however I believe that this is a classic case of wealth redistribution from the impatient to the patient imo
Crystal ball:
DOC has performed and will continue to do the hard work, ie they declared their strategy, they are following it, Q on Q Revenue growth is proof, post Covid, revenue continues to grow, therefore we have achieved a major derisk point on the strategy test

Next Q will be a min 20% growth on last, as will the next and the next
There will be further announcements regarding growth, either organic through partnerships etc or acquisition based
With these growth stocks in this phase (where performance is lagging the MF pump effect) it is difficult to pick the bottom as the short term views sell out.
One day, and you cannot pick it, everyone wakes up and back it goes to +$1 (when performance catches up with the MF pump effect)
My opinion only
cheers